Skip to content
lifestyle.celebhomes.net
Home
Sample Page
Author:
Sparrow Pharmaceuticals
Sparrow Pharmaceuticals to Present Phase 2a Results for Clofutriben in Type 2 Diabetes at the 2026 American Diabetes Association (ADA) Scientific Session
May 29, 2026
Sparrow Appoints Biopharmaceutical Industry Veteran, Carlo Incerti, M.D. to its Board of Directors
February 10, 2026